Gland Pharma Lists At 13% Premium On Debut

Gland Pharma made its debut listing at a premium of 13.4 percent at Rs 1,701 on BSE on Friday when compared to its final issue price of Rs 1,500 per share. The fast-growing injectable-focused B2B company closed its IPO (initial public

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/2Hi4n9i